The interaction between COVID-19 and ACE2 receptor leads to depressed levels of ACE2, which leads to hyper-inflammation, vasoconstriction, coagulation, and hypertension and increases the risk of ischemic strokes. This evidence concerns the gene ACE2 and COVID-19.